Key Highlights of the Report: Rising Prevalence of Type 2 Diabetes and Obesity: The global novel cases of type 2 diabetes and obesity are pivotal to the surging demand for GLP-1 analogues. These drugs are effective for controlling blood sugar and help in the process of weight loss and for this reason, they are preferred most of the time. It contributes to the calmer for such therapies because...